<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>61(1)</volume><submitter>Alcicek S</submitter><funding>Else Kröner-Fresenius-Stiftung (EKFS)</funding><funding>Deutsche Krebshilfe</funding><funding>Mildred Scheel Career Center Frankfurt (Deutsche Krebshilfe)</funding><funding>Else Kröner-Fresenius-Stiftung</funding><funding>LOEWE grant within the CePTER Consortium</funding><pubmed_abstract>&lt;h4>Background&lt;/h4>Emerging evidence suggests that fasting could play a key role in cancer treatment. Its metabolic effects on gliomas require further investigation.&lt;h4>Purpose&lt;/h4>To design a multi-voxel &lt;sup>1&lt;/sup>H/&lt;sup>31&lt;/sup>P MR-spectroscopic imaging (MRSI) protocol for noninvasive metabolic monitoring of cerebral, fasting-induced changes on an individual patient/tumor level, and to assess its technical reliability/reproducibility.&lt;h4>Study type&lt;/h4>Prospective.&lt;h4>Population&lt;/h4>MRS phantom. Twenty-two patients (mean age = 61, 6 female) with suspected WHO grade II-IV glioma examined before and after 72-hour-fasting prior to biopsy/resection.&lt;h4>Field strength/sequence&lt;/h4>3-T, &lt;sup>1&lt;/sup>H decoupled 3D &lt;sup>31&lt;/sup>P MRSI, 2D &lt;sup>1&lt;/sup>H sLASER MRSI at an echo time of 144 msec,</pubmed_abstract><journal>Journal of magnetic resonance imaging : JMRI</journal><pagination>426-438</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11645487</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>2D &lt;sup>1&lt;/sup>H sLASER Long-TE and 3D &lt;sup>31&lt;/sup>P Chemical Shift Imaging at 3 T for Monitoring Fasting-Induced Changes in Brain Tumor Tissue.</pubmed_title><pmcid>PMC11645487</pmcid><pubmed_authors>Ronellenfitsch MW</pubmed_authors><pubmed_authors>Weber KJ</pubmed_authors><pubmed_authors>Dive I</pubmed_authors><pubmed_authors>Thomas DC</pubmed_authors><pubmed_authors>Pilatus U</pubmed_authors><pubmed_authors>Wenger KJ</pubmed_authors><pubmed_authors>Czabanka M</pubmed_authors><pubmed_authors>Steinbach JP</pubmed_authors><pubmed_authors>Hattingen E</pubmed_authors><pubmed_authors>Forster MT</pubmed_authors><pubmed_authors>Alcicek S</pubmed_authors><pubmed_authors>Prinz V</pubmed_authors></additional><is_claimable>false</is_claimable><name>2D &lt;sup>1&lt;/sup>H sLASER Long-TE and 3D &lt;sup>31&lt;/sup>P Chemical Shift Imaging at 3 T for Monitoring Fasting-Induced Changes in Brain Tumor Tissue.</name><description>&lt;h4>Background&lt;/h4>Emerging evidence suggests that fasting could play a key role in cancer treatment. Its metabolic effects on gliomas require further investigation.&lt;h4>Purpose&lt;/h4>To design a multi-voxel &lt;sup>1&lt;/sup>H/&lt;sup>31&lt;/sup>P MR-spectroscopic imaging (MRSI) protocol for noninvasive metabolic monitoring of cerebral, fasting-induced changes on an individual patient/tumor level, and to assess its technical reliability/reproducibility.&lt;h4>Study type&lt;/h4>Prospective.&lt;h4>Population&lt;/h4>MRS phantom. Twenty-two patients (mean age = 61, 6 female) with suspected WHO grade II-IV glioma examined before and after 72-hour-fasting prior to biopsy/resection.&lt;h4>Field strength/sequence&lt;/h4>3-T, &lt;sup>1&lt;/sup>H decoupled 3D &lt;sup>31&lt;/sup>P MRSI, 2D &lt;sup>1&lt;/sup>H sLASER MRSI at an echo time of 144 msec,</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jan</publication><modification>2026-07-15T08:13:16.635Z</modification><creation>2025-04-04T01:54:58.019Z</creation></dates><accession>S-EPMC11645487</accession><cross_references><pubmed>38722043</pubmed><doi>10.1002/jmri.29422</doi></cross_references></HashMap>